Comparative Safety of Bone Remodeling Agents with a Focus on Osteoporosis Therapies
- 8 March 2001
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (3) , 239-250
- https://doi.org/10.1177/00912700122010050
Abstract
This article reviews the different treatments currently available for osteoporosis and examines the benefits and adverse events that are associated with each. While emphasizing safety considerations, this review summarizes the following treatments for osteoporosis: calcium supplements, fluoride, hormone replacement therapy, raloxifene, bisphosphonates, salmon calcitonin, and calcitriol. Before prescribing any of these agents, the clinician should review the risk/benefit profile of each drug in the context of the individual patient's history, concomitant diseases, concurrent medications, and general physical condition.Keywords
This publication has 85 references indexed in Scilit:
- Pharmacological Management of Osteoporosis in Postmenopausal WomenDrugs & Aging, 1999
- Estrogen Replacement Attenuates Effects of Scopolamine and Lorazepam on Memory Acquisition and RetentionHormones and Behavior, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Hormone replacement therapy and high incidence of breast cancer between mammographic screensThe Lancet, 1997
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Esophageal Ulceration Due to AlendronateEndoscopy, 1996
- Intranasal Salcatonin (Salmon Calcitonin)Drugs & Aging, 1996
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980